Cardiopulmonary Research Science and Technology Institute, Dallas, Tex, USA.
J Thorac Cardiovasc Surg. 2010 Oct;140(4):823-8. doi: 10.1016/j.jtcvs.2009.11.065. Epub 2010 Mar 17.
Advances in technology such as epicardial bipolar radiofrequency pulmonary vein isolation, ganglionated plexi identification, and isolation and thoracoscopic left atrial appendage exclusion have enabled less invasive surgical options for management of atrial fibrillation.
We performed a prospective, nonrandomized study of consecutive patients with symptomatic paroxysmal atrial fibrillation undergoing a video-assisted, minimally invasive surgical ablation procedure. The procedure consisted of bilateral, epicardial pulmonary vein isolation with bipolar radiofrequency, partial autonomic denervation, and selective excision of the left atrial appendage. Minimum follow-up was 1 year with long-term monitoring (24-hour continuous, 14-day event or pacemaker interrogation).
Between March 2005 and January 2008, 52 patients (35 male), mean age 60.3 years (range, 42-79 years) underwent the procedure. The left atrial appendage was isolated in 88.0% (44/50). Average hospital stay was 5.2 days (range 3-10 days). There were no operative deaths or major adverse cardiac events. On long-term monitoring, freedom from atrial fibrillation/flutter/tachycardia was 86.3% (44/51) and 80.8% (42/52) at 6 and 12 months, respectively. Antiarrhythmic drugs were stopped in 33 of 37 patients and warfarin in 30 of 37 of the patients in whom ablation was successful at 12 months. Freedom from symptoms attributed to atrial fibrillation/flutter/tachycardia was 78.0% (39/50) at 6 months and 63.8% (30/47) at 12 months.
Minimally invasive surgical ablation is effective in the management of paroxysmal atrial fibrillation as evidenced by freedom from atrial arrythmias by long-term monitoring at 12 months. Measuring success using clinical symptoms underestimated clinical success as compared with long-term monitoring.
心外膜双极射频肺静脉隔离、神经节丛鉴定和隔离以及胸腔镜左心耳排除等技术的进步,为管理心房颤动提供了微创的手术选择。
我们对连续接受视频辅助、微创外科消融手术的有症状阵发性心房颤动患者进行了前瞻性、非随机研究。该手术包括双侧心外膜肺静脉双极射频隔离、部分自主神经去神经支配和选择性切除左心耳。最少随访 1 年,进行长期监测(24 小时连续、14 天事件或起搏器询问)。
2005 年 3 月至 2008 年 1 月,52 例患者(35 例男性),平均年龄 60.3 岁(范围,42-79 岁)接受了该手术。左心耳被隔离在 88.0%(44/50)。平均住院时间为 5.2 天(范围 3-10 天)。无手术死亡或重大心脏不良事件。在长期监测中,无房颤/房扑/心动过速的生存率分别为 86.3%(44/51)和 80.8%(42/52),分别为 6 个月和 12 个月。37 例成功消融的患者中有 33 例停止使用抗心律失常药物,30 例停止使用华法林。6 个月时,与房颤/房扑/心动过速相关症状无复发的生存率为 78.0%(39/50),12 个月时为 63.8%(30/47)。
微创外科消融术在阵发性心房颤动的治疗中是有效的,这一点在 12 个月的长期监测中无房性心律失常的情况下得到了证明。与长期监测相比,使用临床症状来衡量手术成功低估了临床成功率。